GOOD CHARTING LOOKOUT READ BELOW
I decided to do another
GOOD CHARTING LOOKOUT READ BELOW
I decided to do another chart work up on RMHB!!
Barchart shows the following info:
20% BUY for SHORT TERM FUTURE
75% BUY for MID TERM FUTURE
67% BUY for LONG TERM FUTURE
OVERALL BUY IS 48%
NOW FOR THE CHARTING INFO:
50-100 Day MACD Oscillator shows BUY!
With that indicator it shows its STRENGTH IS RATED AT MAXIMUM
Direction of that indicator show STRONGEST!
1st resistance at .1116
2nd resistance at .1153
RSI YESTERDAY 49.22-that needs to go up
AROON Oscillator still HOLDING STRONG AT 40! A GOOD LEVEL BEGINS AT 0 and HIGHER so 40 is PRETTY GOOD!
ADX
+D 26.55
-D 21.46 WHEN THE +D is HIGHER THAN THE -D THATS A GOOD THING!
ICHIMOKU CLOUD FULL INDICATOR STILL LOOKING GOOD FUTURE PREDICITIONS LOOK POSITIVE FOR THE NEXT 3 WEEKS OUT
PARABOLIC SAR INDICATOR IS STILL PUSHING UP WHICH IS A GOOD THING!
AROON INDICATOR
UP 80
DOWN 40 That indicator LOOKS GOOD AS WELL, IT WOULD BE BETTER THOUGH IF THE UP WAS EVEN HIGHER UP ALL THE WAY TO 100 AND THEN THE DOWN GOING LOWER, OVERALL STILL GOOD THOUGH
HERES SOMETHING GOOD TO KNOW:
AN X WAS FORMED ON THE CHART MARCH 1st WHICH INDICATES A GREAT TIME TO ENTER A BUY POSITION ON RMHB. USUALLY A PERSON HAS UP TO THREE DAYS TO ENTER INTO A TRADE ONCE AN X IS FORMED FOR BEST PROFITS.
WHEN AN X APPEARS ON THE CHART NEXT THAT INDICATES A SELLING POINT, NO SECOND X YET!
ULCER INDEX SITS AT
13.99
That's not a bad number but it would be nice to see that lower of course. The NAME ULCER indicates exactly what you think. And that is, how good or bad a stock really is. Meaning if it will give you an ULCER at a HIGHER NUMBER. I've seen other stocks perform GREAT with an ULCER INDEX HIGHER THAN 13.99. Obviously though, the LOWER THE NUMBER THE BETTER YOU FEEL, HAHA!!
Well, that's all for the chart info today!
I sincerely hope everyone appreciates my work!
ROCK ON RMHB!!
10
Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...
Continue Reading
The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...
Continue Reading
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Top 5 Most Recently Viewed Articles
Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...
Continue Reading
Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...
Continue Reading
Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...
Continue Reading
Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...
Continue Reading
Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...
Continue Reading